Patent · US Active

Method for determining fetal chromosomal abnormality

US9547748B2 · kind B2 · utility

0Cited by
7References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2011
Grant dateJan 17, 2017
Priority date
Expiry dateJun 29, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B30/00
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The current invention is directed to methods for noninvasive detection of fetal genetic abnormalities by large-scale sequencing of nucleotides from maternal biological sample. Further provided are methods to remove GC bias from the sequencing results according to the difference in GC content of a chromosome. The current invention not only makes the detection much more accurate but also represents a comprehensive method for fetal aneuploidy detection including sex chromosome disorders such as XO, XXX, XXY, and XYY, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.